DK3449008T3 - In vitro-fremgangsmåde til identificering af bugspytkirtelkræft eller intraduktal papillær mucinøs neoplasma i bugspytkirtlen - Google Patents

In vitro-fremgangsmåde til identificering af bugspytkirtelkræft eller intraduktal papillær mucinøs neoplasma i bugspytkirtlen Download PDF

Info

Publication number
DK3449008T3
DK3449008T3 DK17720719.8T DK17720719T DK3449008T3 DK 3449008 T3 DK3449008 T3 DK 3449008T3 DK 17720719 T DK17720719 T DK 17720719T DK 3449008 T3 DK3449008 T3 DK 3449008T3
Authority
DK
Denmark
Prior art keywords
pancil
papillar
neoplasma
puppy
mucinous
Prior art date
Application number
DK17720719.8T
Other languages
English (en)
Inventor
Garangou Antoni Castells
Cos Meritxel Gironella
Original Assignee
Advanced Marker Discovery S L
Centro De Investig Biomedica En Red
Hospital Clinic Barcelona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Marker Discovery S L, Centro De Investig Biomedica En Red, Hospital Clinic Barcelona filed Critical Advanced Marker Discovery S L
Application granted granted Critical
Publication of DK3449008T3 publication Critical patent/DK3449008T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
DK17720719.8T 2016-04-26 2017-04-21 In vitro-fremgangsmåde til identificering af bugspytkirtelkræft eller intraduktal papillær mucinøs neoplasma i bugspytkirtlen DK3449008T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382182.0A EP3239303A1 (en) 2016-04-26 2016-04-26 In vitro method for identifying pancreatic cancer or intraductal papillary mucinous neoplasm of the pancreas
PCT/EP2017/059498 WO2017186588A1 (en) 2016-04-26 2017-04-21 In vitro method for identifying pancreatic cancer or intraductal papillary mucinous neoplasm of the pancreas

Publications (1)

Publication Number Publication Date
DK3449008T3 true DK3449008T3 (da) 2021-12-06

Family

ID=56081440

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17720719.8T DK3449008T3 (da) 2016-04-26 2017-04-21 In vitro-fremgangsmåde til identificering af bugspytkirtelkræft eller intraduktal papillær mucinøs neoplasma i bugspytkirtlen

Country Status (9)

Country Link
US (1) US11104959B2 (da)
EP (2) EP3239303A1 (da)
CN (1) CN109563548B (da)
DK (1) DK3449008T3 (da)
ES (1) ES2899386T3 (da)
HU (1) HUE057023T2 (da)
PL (1) PL3449008T3 (da)
PT (1) PT3449008T (da)
WO (1) WO2017186588A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111494632B (zh) * 2020-04-30 2021-03-19 山东农业大学 miR-16-5p作为靶点在调控槲皮素和EGCG协同保护胰岛细胞损伤中的用途
CN111748635B (zh) * 2020-05-27 2022-07-29 北京信诺卫康科技有限公司 胆管癌的miRNA标记物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090099034A1 (en) * 2007-06-07 2009-04-16 Wisconsin Alumni Research Foundation Reagents and Methods for miRNA Expression Analysis and Identification of Cancer Biomarkers
CN101942502B (zh) * 2009-12-24 2014-09-17 北京命码生科科技有限公司 胰腺癌标记物及其检测方法、试剂盒和生物芯片
WO2011075873A1 (zh) * 2009-12-24 2011-06-30 北京命码生科科技有限公司 胰腺癌标记物及其检测方法、试剂盒和生物芯片
US20130310276A1 (en) * 2010-12-22 2013-11-21 Ruprecht-Karls University of Heidelberg Microrna for diagnosis of pancreatic cancer
US9644241B2 (en) * 2011-09-13 2017-05-09 Interpace Diagnostics, Llc Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
US20140100124A1 (en) * 2012-10-04 2014-04-10 Asuragen, Inc. Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
US10093967B2 (en) * 2014-08-12 2018-10-09 The Regents Of The University Of Michigan Detection of nucleic acids

Also Published As

Publication number Publication date
PT3449008T (pt) 2021-12-14
CN109563548B (zh) 2022-06-28
CN109563548A (zh) 2019-04-02
EP3239303A1 (en) 2017-11-01
HUE057023T2 (hu) 2022-04-28
WO2017186588A1 (en) 2017-11-02
US20190330699A1 (en) 2019-10-31
EP3449008A1 (en) 2019-03-06
PL3449008T3 (pl) 2022-01-31
EP3449008B1 (en) 2021-09-08
US11104959B2 (en) 2021-08-31
ES2899386T3 (es) 2022-03-11

Similar Documents

Publication Publication Date Title
CL2017000590A1 (es) Anticuerpos anti-cll-1 e inmunoconjugados
KR20180084817A (ko) 항-siglec-9 항체 및 이의 이용 방법
BR112017022917A2 (pt) dispositivo de acoplamento direcional e métodos de uso com o mesmo.
CR20180013A (es) Anticuerpos anti-tau y métodos de uso.
CR20170240A (es) Anticuerpos anti-interleucina-33 y sus usos
DK3439635T3 (da) Formuleringer til behandling af fast tumor
CR20190271A (es) Anticuerpos antitau y métodos de uso
DK3411393T3 (da) Administration af manipulerede t-celler til behandling af cancere i centralnervesystemet
DK3531029T3 (da) Subatmosfærisk varme- og kølesystem
CL2018001139A1 (es) Anticuerpos anti-htra1 y métodos de uso de los mismos.
DK3532067T3 (da) Liposomal formulering til anvendelse til behandling af cancer
CL2019000049A1 (es) Procesos para la preparación de oxipicolinamidas 4 - alkoxi - (acil o aquil).
DK3468604T3 (da) Farmaceutiske kombinationer til behandling af cancer
DK3293201T3 (da) Kombinering af adenovirus og checkpoint-inhibitorer til behandling af cancer
FR3056552B1 (fr) Harpon d'ancrage externe pour aeronef
DK3482137T3 (da) Kombineret varme- og kølesystem
MA40524A (fr) Dérivés d'adrénomédulline stabilisés et leur utilisation
ITUA20161636A1 (it) Impianto termico integrato multisorgente
DK3449008T3 (da) In vitro-fremgangsmåde til identificering af bugspytkirtelkræft eller intraduktal papillær mucinøs neoplasma i bugspytkirtlen
DK3577237T3 (da) Fremgangsmåde til indikation af en tilstedeværelse eller ikke-tilstedeværelse af prostatacancer hos individer med bestemte karakteristika
ITUA20161599A1 (it) Contenitore e procedimento per la realizzazione dello stesso
DK3545109T3 (da) In vitro-fremgangsmåde til identificering af kolorektale adenomer eller kolorektal cancer
ES2874259T8 (es) Composiciones y procedimientos para la detección de Trichomonas vaginalis
IT201600130706A1 (it) 4 amino-2-pirido-biciclo pirimidine e lo uso come medicamenti
FR3047559B1 (fr) Detecteur d'immersion et aeronef